InvestorsHub Logo

jbog

10/12/11 6:14 PM

#6455 RE: pollyvonwog #6453

polly,

I'm sure you're right on that account. But as we have seen, be it Teva or WPI, the earnings won't even move their needle.

I don't think this was ever a Teva item at all, but more of an anti-Momenta item. I haven't heard one peep out of Teva or any analyst regarding Teva's application since Amphastar was approved.